Thomas McGowan
Overview
Explore the profile of Thomas McGowan including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
29
Citations
424
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kumar P, Johnson J, McGowan T, Chambers M, Heydarian M, Mehta S, et al.
Methods Mol Biol
. 2024 Oct;
2859:109-128.
PMID: 39436599
Proteogenomics is a growing "multi-omics" research area that combines mass spectrometry-based proteomics and high-throughput nucleotide sequencing technologies. Proteogenomics has helped in genomic annotation for organisms whose complete genome sequences became...
2.
Zibelman M, MacFarlane 4th A, Costello K, McGowan T, ONeill J, Kokate R, et al.
Nat Commun
. 2023 Jul;
14(1):4513.
PMID: 37500647
This phase I, dose-escalation trial evaluates the safety of combining interferon-gamma (IFN-γ) and nivolumab in patients with metastatic solid tumors. Twenty-six patients are treated in four cohorts assessing increasing doses...
3.
Rajczewski A, Mehta S, Nguyen D, Gruning B, Johnson J, McGowan T, et al.
Clin Proteomics
. 2021 May;
18(1):15.
PMID: 33971807
Background: The Coronavirus Disease 2019 (COVID-19) global pandemic has had a profound, lasting impact on the world's population. A key aspect to providing care for those with COVID-19 and checking...
4.
Rajczewski A, Mehta S, Nguyen D, Gruning B, Johnson J, McGowan T, et al.
medRxiv
. 2021 Mar;
PMID: 33688669
The Coronavirus Disease 2019 (COVID-19) global pandemic has had a profound, lasting impact on the world's population. A key aspect to providing care for those with COVID-19 and checking its...
5.
Mehta S, Kumar P, Crane M, Johnson J, Sajulga R, Nguyen D, et al.
J Proteome Res
. 2021 Mar;
20(4):2130-2137.
PMID: 33683127
metaQuantome is a software suite that enables the quantitative analysis, statistical evaluation. and visualization of mass-spectrometry-based metaproteomics data. In the latest update of this software, we have provided several extensions,...
6.
Thuy-Boun P, Mehta S, Gruening B, McGowan T, Nguyen A, Rajczewski A, et al.
J Proteome Res
. 2021 Jan;
20(2):1451-1454.
PMID: 33393790
In this Letter, we reanalyze published mass spectrometry data sets of clinical samples with a focus on determining the coinfection status of individuals infected with SARS-CoV-2 coronavirus. We demonstrate the...
7.
Mehta S, Easterly C, Sajulga R, Millikin R, Argentini A, Eguinoa I, et al.
Proteomes
. 2020 Jul;
8(3).
PMID: 32650610
For mass spectrometry-based peptide and protein quantification, label-free quantification (LFQ) based on precursor mass peak (MS1) intensities is considered reliable due to its dynamic range, reproducibility, and accuracy. LFQ enables...
8.
Geynisman D, Kadow B, Shuch B, Boorjian S, Matin S, Rampersaud E, et al.
J Urol
. 2020 Jun;
204(3):536-537.
PMID: 32574522
No abstract available.
9.
Yaver M, Foo A, Larsen T, Fineberg H, Zeng G, McGowan T, et al.
J Med Imaging Radiat Sci
. 2020 Apr;
51(4):699.
PMID: 32284236
No abstract available.
10.
Geynisman D, Kadow B, Shuch B, Boorjian S, Matin S, Rampersaud E, et al.
J Urol
. 2020 Apr;
204(3):531-537.
PMID: 32250730
Purpose: Everolimus decreases tumor volume of renal angiomyolipomas in patients with tuberous sclerosis. No prospective data are available regarding the effect of everolimus on the growth kinetics in patients with...